| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |